UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments
The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection…
03/04/2020 - 4 minutes
Trends & News
Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M
Eli Lilly will partner Oxford-based Sitryx to develop up to four drug candidates to treat…
03/04/2020 - 2 minutes
iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding
An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which…
02/04/2020 - 3 minutes
Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…
02/04/2020 - 3 minutes
Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop…
02/04/2020 - 3 minutes
Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons Pediatric Trial
The French pharmaceutical company Ipsen has restarted the dosing of its treatment for a rare…
31/03/2020 - 4 minutes
Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant
The Japanese heavyweight Ono Pharmaceutical has recruited Numab Therapeutics for a second time to co-develop…
31/03/2020 - 3 minutes
Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M
Update (31/03/2020): AM-Pharma has raised an extra €47M on top of an existing €116M equity…
31/03/2020 - 3 minutes
Evox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases
The Japanese pharmaceutical company Takeda has struck a deal worth up to €803M with UK…
27/03/2020 - 3 minutes
Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B
AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and…
26/03/2020 - 3 minutes
Novacyt Launches Two-Hour Coronavirus Test After FDA Approval
The French clinical diagnostics specialist Novacyt has announced FDA authorization for its fast and easily…
26/03/2020 - 3 minutes
DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback
French biotech DBV Technologies’ bid for the US approval of a skin patch to treat…
25/03/2020 - 3 minutes
